Human Genome Epidemiology Literature Finder
|
Records 1 - 8 (of 8 Records) |
| Query Trace: Kidney Neoplasms and CHEK2[original query] |
|---|
| CHEK2 is a multiorgan cancer susceptibility gene. American journal of human genetics 2004 Dec 75 (6): 1131-5. Cybulski C, Górski B, Huzarski T, Masoj? B, Mierzejewski M, Debniak T, Teodorczyk U, Byrski T, Gronwald J, Matyjasik J, Zlowocka E, Lenner M, Grabowska E, Nej K, Castaneda J, Medrek K, Szyma?ska A, Szyma?ska J, Kurzawski G, Suchy J, Oszurek O, Witek A, Narod S A, Lubi?ski |
| Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study. Human molecular genetics 2007 Aug 16 (15): 1794-801. Brennan Paul, McKay James, Moore Lee, Zaridze David, Mukeria Anush, Szeszenia-Dabrowska Neonilia, Lissowska Jolanta, Rudnai Peter, Fabianova Eleonora, Mates Dana, Bencko Vladimir, Foretova Lenka, Janout Vladimir, Chow Wong-Ho, Rothman Nathanial, Chabrier Amelie, Gaborieau Valerie, Odefrey Fabrice, Southey Melissa, Hashibe Mia, Hall Janet, Boffetta Paolo, Peto Julian, Peto Richard, Hung Rayjean |
| Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Feb . Näslund-Koch Charlotte, Nordestgaard Børge G, Bojesen Stig |
| Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer. JCO precision oncology 2019 10 3 . Sailer Verena, Eng Kenneth Wa, Zhang Tuo, Bareja Rohan, Pisapia David J, Sigaras Alexandros, Bhinder Bhavneet, Romanel Alessandro, Wilkes David, Sticca Evan, Cyrta Joanna, Rao Rema, Sahota Sheena, Pauli Chantal, Beg Shaham, Motanagh Samaneh, Kossai Myriam, Fontunge Jacqueline, Puca Loredana, Rennert Hanna, Zhaoying Xiang Jenny, Greco Noah, Kim Rob, MacDonald Theresa Y, McNary Terra, Blattner-Johnson Mirjam, Schiffman Marc H, Faltas Bishoy M, Greenfield Jeffrey P, Rickman David, Andreopoulou Eleni, Holcomb Kevin, Vahdat Linda T, Scherr Douglas S, van Besien Koen, Barbieri Christopher E, Robinson Brian D, Fine Howard Alan, Ocean Allyson J, Molina Ana, Shah Manish A, Nanus David M, Pan Qiulu, Demichelis Francesca, Tagawa Scott T, Song Wei, Mosquera Juan Miguel, Sboner Andrea, Rubin Mark A, Elemento Olivier, Beltran Himis |
| Survival of bladder or renal cancer in patients with CHEK2 mutations. PloS one 2021 16 (9): e0257132. Z?owocka-Per?owska El?bieta, D?bniak Tadeusz, S?ojewski Marcin, van de Wetering Thierry, To?oczko-Grabarek Aleksandra, Cybulski Cezary, Scott Rodney J, Lubi?ski J |
| Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing. European urology oncology 2021 10 4 (6): 993-1000. Truong Hong, Sheikh Rania, Kotecha Ritesh, Kemel Yelena, Reisz Peter A, Lenis Andrew T, Mehta Nikita N, Khurram Aliya, Joseph Vijai, Mandelker Diana, Latham Alicia, Ceyhan-Birsoy Ozge, Ladanyi Marc, Shah Neil J, Walsh Michael F, Voss Martin H, Lee Chung-Han, Russo Paul, Coleman Jonathan A, Hakimi A Ari, Feldman Darren R, Stadler Zsofia K, Robson Mark E, Motzer Robert J, Offit Kenneth, Patil Sujata, Carlo Maria |
| Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care-Checking CHEK2. JAMA oncology 2022 9 8 (11): 1598-1606. Bychkovsky Brittany L, Agaoglu Nihat B, Horton Carolyn, Zhou Jing, Yussuf Amal, Hemyari Parichehr, Richardson Marcy E, Young Colin, LaDuca Holly, McGuinness Deborah L, Scheib Rochelle, Garber Judy E, Rana Huma |
| Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma. medRxiv : the preprint server for health sciences 2023 1 . Han Seunghun, Camp Sabrina Y, Chu Hoyin, Collins Ryan, Gillani Riaz, Park Jihye, Bakouny Ziad, Ricker Cora A, Reardon Brendan, Moore Nicholas, Kofman Eric, Labaki Chris, Braun David, Choueiri Toni K, AlDubayan Saud H, Van Allen Eliezer |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: